(以下内容从华福证券《从政策优化到价值发现:医药产业升级下的投资新机遇》研报附件原文摘录)近期观点1.集采政策显示积极信号2.非肿瘤领域成为研发新焦点3.复杂技术平台迎来黄金发展期4.线上零售渠道价值凸显5.出海与CXO全球化构成双重驱动投资建议基于对当前医药产业结构性转型的深入分析,投资布局应重点关注以下三条高景气产业链:一是CXO,在产业全球化与研发外包深化的趋势下,其复合增长率显著高于全球...
Source Link(以下内容从华福证券《从政策优化到价值发现:医药产业升级下的投资新机遇》研报附件原文摘录)近期观点1.集采政策显示积极信号2.非肿瘤领域成为研发新焦点3.复杂技术平台迎来黄金发展期4.线上零售渠道价值凸显5.出海与CXO全球化构成双重驱动投资建议基于对当前医药产业结构性转型的深入分析,投资布局应重点关注以下三条高景气产业链:一是CXO,在产业全球化与研发外包深化的趋势下,其复合增长率显著高于全球...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.